Please login to the form below

Not currently logged in
Email:
Password:

Vokanamet

This page shows the latest Vokanamet news and features for those working in and with pharma, biotech and healthcare.

FDA approves J&J’s diabetes combo

FDA approves J&J’s diabetes combo

The FDA approval follows the decision by the European Commission in April this year to approval a combination of canagliflozin and metformin under the name Vokanamet.

Latest news

  • Boehringer/Lilly's Jardiance approved in US Boehringer/Lilly's Jardiance approved in US

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • NICE backs Janssen’s once-daily diabetes drug NICE backs Janssen’s once-daily diabetes drug

    Janssen's Invokana was also granted European approval for a fixed dose combination with metformin that will be marketed as Vokanamet, putting it on an equal setting to AstraZeneca, which markets

  • EC approves drugs for diabetes and Crohn’s disease EC approves drugs for diabetes and Crohn’s disease

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • J&J wins EU approval for diabetes combo J&J wins EU approval for diabetes combo

    Vokanamet combines Invokana and metformin. Johnson &Johnson's diabetes portfolio continues to grow apace with the news that its combination treatment Vokanamet has been approved in the EU. ... Vokanamet combines J&J's already-available Invokana

  • Janssen Invokana combination recommended for European approval Janssen Invokana combination recommended for European approval

    The CHMP's positive opinion on Vokanamet puts the type 2 diabetes treatment on the path to full approval in the region within the next three months. ... The company will have to implement a pharmacovigilance plan for Vokanamet as part of any marketing

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....